Outlook Therapeutics OTLK
NASDAQ OTLK
$0.56 +0.04 (+7.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Minority Interest (2015 - 2016)

Updated

Outlook Therapeutics (OTLK) reported Minority Interest of $17.4 million for fiscal Q2 2016 (quarter ended Mar 31, 2016).

Analysis

Outlook Therapeutics (OTLK) Minority Interest (2015 - 2016) Analysis & Trends

At the end of FY2015 (ended Sep 30, 2015), Outlook Therapeutics posted Minority Interest of $27.32 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Outlook Therapeutics 77.51 Mn 41.76 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 17.40 Mn
Sep 30, 2015 27.32 Mn
API Access

Outlook Therapeutics Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=OTLK&period=max&api_key=YOUR_API_KEY